Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II).

Legrand VM, Garg S, Serruys PW, Virtanen KS, Szurawitzki G, Voudris V, Fontanelli A, Endersen K, Kranjec I, Rademaker T, Stefanidis CI, Wittebols K.

EuroIntervention. 2011 Feb;6(7):838-45. doi: 10.4244/EIJV6I7A144.

PMID:
21252018
[PubMed - indexed for MEDLINE]
Free Article
2.

Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II).

Kukreja N, Serruys PW, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Goedhart D, Macours N, Stoll HP; ARTS-II Investigators.

Heart. 2009 Jul;95(13):1061-6. doi: 10.1136/hrt.2008.157735. Epub 2009 Mar 19.

PMID:
19304671
[PubMed - indexed for MEDLINE]
3.

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.

Vaina S, Voudris V, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll HP, Cokkinos DV, Stefanadis C, Serruys PW; ARTSII.

EuroIntervention. 2009 Jan;4(4):492-501.

PMID:
19284072
[PubMed - indexed for MEDLINE]
4.

5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP; ARTS II Investigators.

J Am Coll Cardiol. 2010 Mar 16;55(11):1093-101. doi: 10.1016/j.jacc.2009.11.049. Epub 2010 Feb 18.

PMID:
20171036
[PubMed - indexed for MEDLINE]
Free Article
5.

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, van Es GA, Wittebols K, Macours N, Stoll HP, Serruys PW.

EuroIntervention. 2010 Apr;5(8):962-7. doi: 10.4244/.

PMID:
20542782
[PubMed - indexed for MEDLINE]
6.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW; ARTS-II Investigators.

J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.

PMID:
19055986
[PubMed - indexed for MEDLINE]
Free Article
7.

Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II).

Routledge HC, Lefèvre T, Colombo A, Oldroyd KG, Hamm CW, Guagliumi G, von Scheidt W, Guetta V, Ruzyllo W, Wittebols K, Goedhart DM, Serruys PW.

EuroIntervention. 2009 Jun;5(2):190-6.

PMID:
20449929
[PubMed - indexed for MEDLINE]
8.

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.

Serruys PW, Ong AT, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, O'Malley AJ, Bressers M, Donohoe D.

EuroIntervention. 2005 Aug;1(2):147-56.

PMID:
19758896
[PubMed]
9.

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP; REALITY Trial Investigators.

JAMA. 2006 Feb 22;295(8):895-904.

PMID:
16493102
[PubMed - indexed for MEDLINE]
10.

Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?

Manabe S, Shimokawa T, Fukui T, Fumimoto KU, Ozawa N, Seki H, Takanashi S.

J Card Surg. 2009 May-Jun;24(3):234-9. doi: 10.1111/j.1540-8191.2008.00789.x.

PMID:
19438773
[PubMed - indexed for MEDLINE]
11.

Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.

Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.

J Invasive Cardiol. 2006 Dec;18(12):577-83.

PMID:
17197706
[PubMed - indexed for MEDLINE]
12.

Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.

Valgimigli M, Dawkins K, Macaya C, de Bruyne B, Teiger E, Fajadet J, Gert R, De Servi S, Ramondo A, Wittebols K, Stoll HP, Rademaker TA, Serruys PW.

J Am Coll Cardiol. 2007 Jan 30;49(4):431-41. Epub 2007 Jan 12.

PMID:
17258088
[PubMed - indexed for MEDLINE]
Free Article
14.

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.

Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW.

Circulation. 2004 May 18;109(19):2273-8. Epub 2004 May 3.

PMID:
15123524
[PubMed - indexed for MEDLINE]
Free Article
15.

Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).

Sarno G, Garg S, Onuma Y, Gutiérrez-Chico JL, van den Brand MJ, Rensing BJ, Morel MA, Serruys PW; ARTS-II Investigators.

Am J Cardiol. 2010 Nov 15;106(10):1369-75. doi: 10.1016/j.amjcard.2010.06.069. Epub 2010 Oct 1.

PMID:
21059423
[PubMed - indexed for MEDLINE]
16.

The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.

van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen J, Venema AC, Serruys PW, Bogers AJ.

Eur Heart J. 2005 Apr;26(7):675-81. Epub 2005 Jan 6.

PMID:
15637087
[PubMed - indexed for MEDLINE]
Free Article
17.

One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial.

van Hout BA, Serruys PW, Lemos PA, van den Brand MJ, van Es GA, Lindeboom WK, Morice MC.

Heart. 2005 Apr;91(4):507-12.

PMID:
15772214
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.

Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.

Circulation. 2007 Sep 11;116(11 Suppl):I200-6.

PMID:
17846304
[PubMed - indexed for MEDLINE]
Free Article
19.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

PMID:
20946993
[PubMed - indexed for MEDLINE]
Free Article
20.

The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).

Tsuchida K, Colombo A, Lefèvre T, Oldroyd KG, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm CW, Bressers M, Stoll HP, Wittebols K, Donohoe DJ, Serruys PW.

Eur Heart J. 2007 Feb;28(4):433-42. Epub 2007 Jan 31.

PMID:
17267457
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk